Retrospective Study of the Linear™ Hip

Encore Medical

Status: Terminated

Conditions: Osteoarthritis; Femoral Fracture; Correction of a Functional Deformity; Avascular Necrosis; Rheumatoid Arthritis

Treatments: Device: Encore Linear™ Hip System

Study type: Observational

Funder types: Industry

Identifiers

NCT00764959

PS - 800

Details and patient eligibility

About

The purpose of this study is to evaluate the use and efficacy of the Encore Linear™ Hip System in a group of 200 patients for whom data has already been collected.

Enrollment: 200 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Have hip joint disease related to one or more of the following

  • osteoarthritis
  • rheumatoid arthritis
  • femoral fracture
  • correction of a functional deformity
  • avascular necrosis of the natural femoral head

• Skeletal maturity

• Patient is likely to be available for evaluation for the duration of the study

• Able and willing to sign the informed consent and follow study procedures

• Patient is not pregnant

• No infection present

• No known materials sensitivity

• Patient is over 18 years of age

Exclusion criteria

• Skeletal immaturity
• Infection or sepsis
• Insufficient bone quality that may affect the stability of the implant
• Muscular, neurologic or vascular deficiencies which compromise the affected extremity
• Alcoholism or other addictions
• Prisoners
• High levels of physical activity
• Patient is pregnant
• Loss of ligamentous structures
• Materials sensitivity
• Patient is under 18 years of age

Trial design

200 participants in 1 patient group

Linear Hip

Description:

Encore Linear Hip System

Treatment:

Device: Encore Linear™ Hip System